Remeditex Ventures LLC

Insider CIK 1627363 · APEN 10% owner · BLCM 10% owner · SOLY 10% owner · MNLO 10% owner

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
SOLY Soliton, Inc.	D To issuer deriv	2021-12-16	2021-12-17	250,000	—	$0	0	SEC↗
SOLY Soliton, Inc.	D To issuer deriv	2021-12-16	2021-12-17	170,808	—	$0	0	SEC↗
SOLY Soliton, Inc.	D To issuer	2021-12-16	2021-12-17	9,214,277	$22.60	$208.24M	0	SEC↗
SOLY Soliton, Inc.	P Buy	2020-06-30	2020-07-01	120,481	$8.30	$1000.0K	9,214,277	SEC↗
APEN LPATH, INC	J Other	2019-12-29	2016-12-30	1,309,392	—	$0	1,309,392	SEC↗
SOLY Soliton, Inc.	P Buy deriv	2019-10-11	2019-10-15	170,808	—	$0	420,808	SEC↗
SOLY Soliton, Inc.	P Buy	2019-10-11	2019-10-15	155,280	—	$0	9,093,796	SEC↗
SOLY Soliton, Inc.	P Buy deriv	2019-06-19	2019-06-19	250,000	—	$0	250,000	SEC↗
SOLY Soliton, Inc.	P Buy	2019-06-19	2019-06-19	357,143	—	$0	8,938,516	SEC↗
MNLO Menlo Therapeutics, Inc.	C Conversion deriv	2018-01-29	2018-01-29	821,596	—	$0	0	SEC↗
MNLO Menlo Therapeutics, Inc.	C Conversion deriv	2018-01-29	2018-01-29	2,351,097	—	$0	0	SEC↗
MNLO Menlo Therapeutics, Inc.	C Conversion deriv	2018-01-29	2018-01-29	7,150	—	$0	0	SEC↗
MNLO Menlo Therapeutics, Inc.	C Conversion	2018-01-29	2018-01-29	304,576	—	$0	2,761,663	SEC↗
MNLO Menlo Therapeutics, Inc.	C Conversion	2018-01-29	2018-01-29	871,583	—	$0	2,457,087	SEC↗
MNLO Menlo Therapeutics, Inc.	C Conversion	2018-01-29	2018-01-29	2,650	—	$0	1,585,504	SEC↗
MNLO Menlo Therapeutics, Inc.	P Buy	2018-01-25	2018-01-29	100,000	$17.00	$1.70M	1,582,854	SEC↗
BLCM BELLICUM PHARMACEUTICALS,	C Conversion deriv	2014-12-23	2014-12-23	2,310,806	—	$0	0	SEC↗
BLCM BELLICUM PHARMACEUTICALS,	C Conversion deriv	2014-12-23	2014-12-23	417,009	—	$0	0	SEC↗
BLCM BELLICUM PHARMACEUTICALS,	C Conversion deriv	2014-12-23	2014-12-23	271,055	—	$0	0	SEC↗
BLCM BELLICUM PHARMACEUTICALS,	C Conversion	2014-12-23	2014-12-23	1,359,297	—	$0	1,359,297	SEC↗
BLCM BELLICUM PHARMACEUTICALS,	C Conversion	2014-12-23	2014-12-23	159,444	—	$0	1,518,741	SEC↗
BLCM BELLICUM PHARMACEUTICALS,	C Conversion	2014-12-23	2014-12-23	245,299	—	$0	1,764,040	SEC↗
BLCM BELLICUM PHARMACEUTICALS,	J Other	2014-12-23	2014-12-23	43,563	—	$0	1,807,603	SEC↗
BLCM BELLICUM PHARMACEUTICALS,	X Exercise deriv	2014-12-17	2014-12-19	271,055	—	$0	0	SEC↗
BLCM BELLICUM PHARMACEUTICALS,	X Exercise deriv	2014-12-17	2014-12-19	271,055	—	$0	159,444	SEC↗